DionyMed Archives

Debra BorchardtOctober 29, 2019

DionyMed Brands Inc. (CSE: DYME; OTCQB: DYMEF) is headed to bankruptcy. The cannabis company had been unable to meet the demands of its creditors and announced today it was unable to attract a viable transaction to restructure its debts. The company also said tried to seek a sale of its assets outside of a court […]

Debra BorchardtOctober 17, 2019

DionyMed Brands Inc. (CSE: DYME)(OTCQB: DYMEF) on Wednesday announced that the company’s CEO Edward Fields and Mark Zinselmeier, the company’s Interim COO, have both resigned effective immediately. Mr. Fields also resigned as a director of the Company and as an officer of the subsidiaries of the Company. Today, it told the public that GLAS USA […]

William SumnerSeptember 19, 2019

It’s time for your Daily Hit of cannabis financial news for September 19, 2019. On the Site Eaze California delivery software company Eaze has finally gotten fed up with DionyMed’s (CSE: DYME) (OTC:DYMEF) accusations and filed a countersuit on Tuesday against the company. For DionyMed, it comes at a pretty bad time. The company just […]

Debra BorchardtSeptember 19, 2019

California delivery software company Eaze has finally gotten fed up with DionyMed’s (CSE: DYME) (OTC:DYMEF) accusations and filed a countersuit on Tuesday against the company. For DionyMed, it comes at a pretty bad time. The company just accepted the resignation of its COO Pete Hilliard and is restructuring its debt. Plus, the stock was halted […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: DionyMed

DionyMed Stops Trading, Heads For Bankruptcy

Dionymed Implodes As CEO, COO Resign, Creditor Demands $24 Million

The Daily Hit: September 19, 2019

Eaze Fights Back As DionyMed Stock Trading Resumes

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox